Teens with chronic pain try coaching to ease suffering
NCT ID NCT05834725
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a resilience coaching program (PRISM) for 260 teens aged 12-17 with chronic musculoskeletal pain. The goal was to see if coaching improves daily function, reduces distress, and lessens pain compared to usual care. Participants completed surveys and coaching sessions, with results measured at 3 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Resilience coaching program (PRISM)
- What this could lead to
- If it works, this could offer a new, non-drug way to help teens with chronic pain feel better and function more normally.
- What could go wrong
- This is a small pilot study, so results may not apply to all teens. The coaching may not work better than usual care, and benefits might be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
260 people
The number who actually took part.
- Started
-
May 2023
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patient participants aged 12-17 years, * newly diagnosed with chronic musculoskeletal pain, defined as bone, joint, muscle, or related soft tissue pain lasting ≥ 3 months * willing to provide informed consent/assent * one caregiver willing to consent and participate in dyad * dyad identifies English as primary language * mild or greater impairment due to pain (defined as Patient Reported Outcomes Measurement Information System Pain Interference T-score ≥ 60 at time of last clinic visit and/or self- or parent- reported impairment of activities of daily living due to pain at time of screening) Exclusion Criteria: * unable to provide assent and/or without a legal guardian able to provide consent for the study subject or themselves * isolated/localized head pain or abdominal pain * complex regional pain syndrome (CRPS) * Receiving cognitive behavioral therapy at time of screening
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pain syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Muscle therapy may restore strength in dialysis patients
- Writing with self-compassion may soften the strain of caregiving
- Zapping the brain to fight teen pain: a new hope?
- Your DNA may hold the key to personalized pain relief
- Which injection eases knee pain better: steroid or sugar?
- Could online therapy ease the stress of raising a child with autism?